The Journal of Infectious Diseases · 1999 · 34 citations · 10 references
PharmacyInfectious DiseasesPharmacotherapyAntimicrobial ResistanceInfectious Disease PharmacotherapyParasite EpidemiologyAntiparasitic Drug ResistanceAntiparasitic PharmacologyAntiparasitic PharmacotherapyAntiparasitic ResistanceAntiparasitic TherapyMalariaIn Vivo Efficacy TestingIn Vivo Resistance AssaysMalaria ResistanceParasite Clearance MechanismsPlasmodium FalciparumThick Blood Smear ExaminationThick Smear StainingTreatment Of Malaria
Ninety-four patients with falciparum malaria were treated with mefloquine (1000-mg single dose) and remained hospitalized in a malaria-free area for a minimum of 28 days. There was 1 parasitologic failure (grade I resistance [RI]) for a 99% cure rate (95% confidence interval, 94.2%-99.7%). Mean parasite clearance time by thick smear was 45.7 h (SD, 11.4 h). The subject in whom therapy failed had a parasite clearance time (71 h) >2 SD above the population mean. His plasma mefloquine level 48 h after administration was lower (578 ng/mL) than the range of levels from 8 randomly selected cured subjects (834-2360 ng/mL). The IC50 to mefloquine for the recrudescent strain of the RI failure was in the upper 90th percentile of IC50 values from 30 cured subjects. These results show a high mefloquine cure rate but document the onset and mechanism of the emergence of resistance.
10
L J Bruce-Chwatt · Monograph series - World Health Organization · 1981 · 276 citations
H. Kyle Webster, Kosol Yongvanitchit, Lorrin Pang et al. · American Journal of Tropical Medicine and Hygiene · 1985 · 105 citations
Yngve Bergqvist, Urban Hellgren, Frederick C. Churchill · Journal of Chromatography B Biomedical Sciences and Applications · 1988 · 55 citations